AstraZeneca must now deliver on its own promises

British pharma group may have seen off Pfizer but unsettled investors will require delivery on challenging targets it set itself in defence of the assault by US rival as share price falls





The Counter Ruck

The Counter Ruck

Sign up to the Irish Times weekly rugby digest for the view from the press box with Gerry Thornley


YOU MAY ALSO LIKE...

Common Ground

How does a post-Brexit world shape the identity and relationship of these islands